STI & LTI have become a joke


























Payout is in April as our worthless leadership finds another way to defer paying us like raises last year.
We can complain about this on CP OR we can leave for greener pastures. Bayer has lost all sort of loyalty and respect for anyone who is below a 3.0, except when they need to cut muscle which they will then beware.... what goes around will come around.
 
























Is there an LTI payout this year? If so, what is % and when will it be paid to employees?
I know there will be both the STI is usually April and the LTI was suppose to be January but they bumped that payout to April so LTI which is grossly reduced since 4 years ago- shameful- is still coming however the amount t I lost in it has gone directly into Bills paycheck. Thanks fucker
 








I know there will be both the STI is usually April and the LTI was suppose to be January but they bumped that payout to April so LTI which is grossly reduced since 4 years ago- shameful- is still coming however the amount t I lost in it has gone directly into Bills paycheck. Thanks fucker
So what are your roles? Expected target LTI or STI and what are you factually receiving. Let’s say Director, 230k target STI 22% are you saying you only receive 5k as opposed to 44k?
 








So what are your roles? Expected target LTI or STI and what are you factually receiving. Let’s say Director, 230k target STI 22% are you saying you only receive 5k as opposed to 44k?
Absolutely! Keep the math simple; $100K salary, LTI 20% - $20,000. This year’s payout for example 21% so 21% of $20,000! A huge $4,200!!! And that for and AGM or 2.0 grade. Bayer is hardly the company you will make any money at, but they will charge you for driving a little BMW X1 and let you do an short term assignment doing others work so they don't have to fill a position and call it Development instead of cheap labor, which is what it is. Worst place in Pharma to work, period!!!
 








It is concerning to see individuals without the necessary experience leading Marketing initiatives. Take Kerendia as a case in point: the head of Marketing has openly admitted to not completing the essential modules that the sales team must finish. This raises serious doubts about the capacity of someone in that role to develop an effective marketing strategy geared towards growth. Additionally, the close association with Simon, his former chief of staff, highlights a troubling trend where success often appears to be more about connections than actual competence. This issue is further exemplified by various Chief of Staff advancing to higher positions despite a lack of relevant performance under ineffective leaders; we can see this clearly with Market Access, which is overseen by an individual lacking prior experience in that field. It prompts the question: how can the Board overlook the clear need for a rigorous assessment of talent in leadership appointments when the inadequacies are so apparent? Moreover, if there are any doubts, the consistent performance against goals serves as undeniable evidence of the inability to forecast effectively.
That is 100% true. She has admitted to not knowing much about Kerendia. What’s even more shocking is she is losing her hair faster than good employees leaving the company. Her forehead is officially a sixhead.